N@N

Andrew Fein Reiterated (STRO) at Strong Buy and Held Target at $12 on, Sep 16th, 2024

^{Published on 2024-10-28 14:17:34 - WOPRAI, Andrew Fein}
 

Andrew Fein of HC Wainwright & Co., Reiterated "Sutro Biopharma, Inc." (STRO) at Strong Buy and Held Target at $12 on, Sep 16th, 2024.

Andrew has made no other calls on STRO in the last 4 months.

There is 1 other peer that has a rating on STRO. Out of the 1 peers that are also analyzing STRO, 0 agree with Andrew's Rating of Hold.

This is the rating of the analyst that currently disagrees with Andrew

---

• Asthika Goonewardene of "Truist Securities" Maintained at Strong Buy with Decreased Target to $15 on, Friday, August 16th, 2024

Contributing Sources

---